Tempus AI builds AI-driven precision medicine solutions for oncology and other complex diseases. The company operates the world's largest library of clinical and molecular data, which it uses to power diagnostic testing, drug discovery, and personalized treatment recommendations. Tempus went public in 2024 on the Nasdaq, backed by a major partnership with Google.
IPO details
IPO date
Wed Jun 12
IPO price
—
First-day close
—
IPO valuation
$11.45B
Market-data summary
Current price
—
Market cap
—
Day range
—
52-week range
—
Data last checked Thu Oct 01. Optional market data is not yet available where shown as —.